Clinical trial · Interventional
Legume Diet Satiety Pilot Study
Legume Diet Satiety and Weight Loss Pilot Study
NCT02269631CI-TRIAL-00036761completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot study is designed to test the effects of a high legume (dried bean) diet on hunger and other indicators of health over the course of eight weeks, compared to a more conventional healthy diet.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Carcinoma | Colorectal Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Obesity | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control diet group | Behavioral | — | UNRESOLVED |
| Legume diet group | Behavioral | — | UNRESOLVED |
| legumes | Other | — | UNRESOLVED |
| Smartpill | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Legume diet group
- description
- Meals will include approximately 1 ½ cups of cooked legumes, such as pinto, baked and navy beans as part of your 2 daily main dishes (lunch and dinner) and additional foods and snacks, preferably from the recommended healthy foods list. The smartpill will be administered at the end of the study.
- interventionNames
- Behavioral: Legume diet group
- Device: Smartpill
- Other: legumes
- type
- ACTIVE_COMPARATOR
- label
- Control diet group
- description
- Meals will be healthy, typical American foods (without legumes) for 2 daily main dishes and additional foods and snacks, preferably from the recommended healthy foods list.The smartpill will be administered at the end of the study.
- interventionNames
- Behavioral: Control diet group
- Device: Smartpill
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * BMI overweight-obese: 25.0-40 kg/m2 * Colonoscopy within the last two years that found ≥1 adenoma * English speaking * Ambulatory, able to come to either food distribution site to pick up food and participate in clinical examinations and laboratory tests Exclusion Criteria: * Serious medical condition (e.g., cancer, heart disease, kidney disease, diabetes) * History of CRC, bowel resection, polyposis syndrome, or inflammatory bowel disease * Smoked regularly in the past year * Dietary restrictions substantially limiting compliance or vegetarian or Vegan diet * Planning on changing diet or exercise behavior in the next 6 months * Regular use of medication that may alter inflammation markers, insulin, glucose, or gut function (i.e. regular use of non-steroidal anti-inflammatory medication, insulin therapy, steroid therapy, or antibiotics)
References
Publications (0)
Data not yet available
No reference posted for this study.